胰高血糖素样肽-1受体激动剂对上消化道内镜的影响:一项Meta分析
本Meta分析纳入13项研究共84,065例患者,评估GLP-1RA对上消化道内镜的影响。GLP-1RA组胃内容物残留率、中止操作率和重复操作率均显著高于对照组,但不良事件率和误吸率两组无显著差异。作者认为调整禁食时间而非常规停用GLP-1RA可能是合理的。
要点
- GLP-1RA使用者上消化道内镜胃内容物残留率显著升高(OR 5.56)。
- GLP-1RA组中止操作率和重复操作率均显著高于对照组。
- 两组不良事件率和误吸率无显著差异。
核心结论
- 使用GLP-1RA与上消化道内镜中胃内容物残留增加及中止操作更频繁相关。
- 不良事件率和误吸率两组似乎无差异,因此调整禁食时间而非常规停用GLP-1RA可能是合理的。
研究设计与样本
- 系统文献检索截至2024年5月,采用随机效应模型进行Meta分析,纳入13项研究共84,065例患者。
- 主要结局为胃内容物残留率,次要结局包括中止操作率、重复操作率、不良事件率和误吸率。
主要发现
- GLP-1RA组胃内容物残留率显著高于对照组(OR 5.56;95%CI 3.35至9.23)。
- 糖尿病患者中GLP-1RA组胃内容物残留率亦升高(OR 2.60;95%CI 2.23至3.02)。
- 校正性别、年龄、体重指数、糖尿病和其他治疗后,GLP-1RA组胃内容物残留率仍升高(校正OR 4.20;95%CI 3.42至5.15)。
- GLP-1RA组中止操作率(OR 5.13;95%CI 3.01至8.75)和重复操作率(OR 2.19;95%CI 1.43至3.35)均高于对照组。
- 两组不良事件率(OR 4.04;95%CI 0.63至26.03)和误吸率(OR 1.75;95%CI 0.64至4.77)无显著差异。
临床怎么用
- 作者认为,调整禁食时间而非常规停用GLP-1RA可能是合理的。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND AIMS: Limited evidence exists regarding the impact of glucagon-like peptide-1 receptor agonists (GLP-1RAs) on upper endoscopy. Therefore, a meta-analysis was conducted to comprehensively review the available evidence on this subject. METHODS: A systematic bibliographic search was carried out until May 2024. Pooled estimates were analyzed using a random-effects model, with results presented as odds ratio (OR) and 95% confidence interval (CI). The primary outcome assessed was the rate of retained gastric content (RGC), while secondary outcomes included rates of aborted and repeated procedures, adverse event rate, and rates of aspiration. RESULTS: This analysis included 13 studies involving a total of 84,065 patients. Patients receiving GLP-1RA therapy exhibited significantly higher rates of RGC (OR, 5.56; 95% CI, 3.35 to 9.23), a trend that was consistent among patients with diabetes (OR, 2.60; 95% CI, 2.23 to 3.02). Adjusted analysis, accounting for variables such as sex, age, body mass index, diabetes, and other therapies, confirmed the elevated rates of RGC in the GLP-1RA user group (adjusted OR, 4.20; 95% CI, 3.42 to 5.15). Furthermore, rates of aborted and repeated procedures were higher in the GLP-1RA user group (OR, 5.13; 95% CI, 3.01 to 8.75; and OR, 2.19; 95% CI, 1.43 to 3.35; respectively). However, no significant differences were found in AE and aspiration rates between the 2 groups (OR, 4.04; 95% CI, 0.63 to 26.03; and OR, 1.75; 95% CI, 0.64 to 4.77; respectively). CONCLUSION: Use of GLP-1RAs is associated with increased retention of gastric contents and more frequent aborted procedures during upper endoscopy. However, the adverse event and aspiration rates do not seem different; therefore, adjusting fasting time instead of routinely withholding GLP-1RAs could be reasonable in these patients.
引用
- Facciorusso A, Ramai D, Dhar J, et al. Effects of Glucagon-Like Peptide-1 Receptor Agonists on Upper Gastrointestinal Endoscopy: A Meta-Analysis. Clin Gastroenterol Hepatol. 2024. PMID: 39142543. doi:10.1016/j.cgh.2024.07.021
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。